Home » KENYA: COST OF DRUGS AT STAKE IN NEW ROW WITH FIRMS

KENYA: COST OF DRUGS AT STAKE IN NEW ROW WITH FIRMS

June 22, 2006

A fresh battle whose outcome will greatly affect the cost of drugs in Kenya has erupted between multinational pharmaceutical companies and independent drug distributors and international aid organizations.

AllAfrica.com (http://allafrica.com/stories/200606220061.html)

KEYWORDS Daily International Pharma Alert

07Dec
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
08Dec
Simplifying Oncology Trials: Make the Most of Remote Monitoring and Decentralization
08Dec
Extractables and Leachables: Taking a Deeper Dive
09Dec
Drug Safety Reporting Requirements: Best Practices for Monitoring, Reporting and Avoiding Regulatory Missteps
15Dec
Promoting & Marketing in the Digital and Virtual World: What Regulatory, Compliance & Marketing Professionals Need to Know

KENYA: COST OF DRUGS AT STAKE IN NEW ROW WITH FIRMS

Upcoming Events

Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

Simplifying Oncology Trials: Make the Most of Remote Monitoring and Decentralization

Extractables and Leachables: Taking a Deeper Dive

Drug Safety Reporting Requirements: Best Practices for Monitoring, Reporting and Avoiding Regulatory Missteps

Promoting & Marketing in the Digital and Virtual World: What Regulatory, Compliance & Marketing Professionals Need to Know

Featured Products

Biological Risk Evaluation and Management for Medical Devices

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

FDA Rejects BeyondSpring’s NDA for Neutropenia Therapy

AMF Medical’s Sigi Insulin System Designated an FDA Breakthrough Device

Novavax to Develop Omicron-Specific COVID-19 Shot

Qiagen and DiaSorin Gain Premarket Approval for TB Test

The Revised ICH E8: A Guide to New Clinical Trial Requirements